Robert M. Cohen

Active 1971–2025

93
Papers
21,189
Citations
76
h-index
92
i10-index

Citations

Citations per year for Robert M. Cohen1972: 1 citations1977: 6 citations1978: 9 citations1979: 10 citations1980: 9 citations1981: 8 citations1982: 10 citations1983: 21 citations1984: 19 citations1985: 17 citations1986: 21 citations1987: 35 citations1988: 31 citations1989: 23 citations1990: 38 citations1991: 35 citations1992: 56 citations1993: 46 citations1994: 70 citations1995: 66 citations1996: 61 citations1997: 104 citations1998: 117 citations1999: 119 citations2000: 163 citations2001: 139 citations2002: 156 citations2003: 167 citations2004: 154 citations2005: 139 citations2006: 145 citations2007: 145 citations2008: 144 citations2009: 164 citations2010: 134 citations2011: 166 citations2012: 138 citations2013: 143 citations2014: 147 citations2015: 118 citations2016: 137 citations2017: 152 citations2018: 123 citations2019: 354 citations2020: 355 citations2021: 316 citations2022: 295 citations2023: 278 citations2024: 774 citations2025: 505 citations2026: 21 citations1973–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,203 citing papers, 33.6% of this breakdownUnited Kingdom: 791 citing papers, 8.3% of this breakdownChina: 446 citing papers, 4.7% of this breakdownGermany: 433 citing papers, 4.6% of this breakdownCanada: 412 citing papers, 4.3% of this breakdownSweden: 366 citing papers, 3.8% of this breakdownAustralia: 323 citing papers, 3.4% of this breakdownItaly: 313 citing papers, 3.3% of this breakdownNetherlands: 299 citing papers, 3.1% of this breakdownFrance: 291 citing papers, 3.1% of this breakdownJapan: 226 citing papers, 2.4% of this breakdownSpain: 215 citing papers, 2.3% of this breakdown
0%33.6%Other 23.1%

Fields

  • Medicine65.3%
  • Biochemistry, Genetics and Molecular Biology13%
  • Neuroscience12.9%
  • Psychology3.6%
  • Environmental Science0.8%
  • Computer Science0.8%
  • Other3.6%

Topics

  • Alzheimer's disease research and treatments7.1%
  • Dementia and Cognitive Impairment Research4.8%
  • Functional Brain Connectivity Studies2.7%
  • Attention Deficit Hyperactivity Disorder2.5%
  • Diabetes Treatment and Management2.5%
  • Diabetes Management and Research2.3%
  • Other78.1%

Coauthors

All papers

Open in search
  1. Donanemab in Early Symptomatic Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer Arnold, Takashi Asada, Yasuhiro Aso, Vikram Atit, Ricardo Ayala, Michael Badruddoja, Hanna Badzio-jagiello, Michal Bajaček, Dávid Barton, David G. Bear, Sabrina Benjamin, Richard Bergeron, Perminder Bhatia, Sandra E. Black, Allan Block, Mohammad Reza Bolouri, Wendy Bond, Jean Bouthillier, Sharon A. Brangman, Bruce J. Brew, Sarah Brisbin, Toby Brisken, Amy Brodtmann, Mark Brody, Jared R. Brosch, Celia Brown, Paul Brownstone, Sylwia Bukowczan, Jeffrey M. Burns, A Cabrera, Horace Capote, Ángel Carrasco, José Yépez, Eric Chavez, Howard Chertkow, Urszula Chyrchel-Paszkiewicz, Anthony Ciabarra, Edward Clemmons, Daniel M. Cohen, Robert M. Cohen, Ian J. Cohen, Mauricio Concha, Brian Costell, Denis Crimmins, Yvette Cruz-pagan, Adolfo Cueli, Robert Cupelo, Maciej Czarnecki, David Darby, P. L. J. Dautzenberg, Peter Paul De Deyn, Jose De La Gandara, Kenneth Deck, David DiBenedetto, Mark DiBuono, Eric Dinnerstein, Ahmet Dirican, Shanker Dixit, Jacek Dobryniewski, Ryan Drake, Peter Drysdale, Ranjan Duara, John P. Duffy, Aaron Ellenbogen, Victor Faradji, Marc Feinberg, Robert Feldman, Simon Fishman, Stephen Flitman, Concetta Forchetti and 209 more - JAMA 2023 cited by 2,562

  2. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2010 cited by 1,422

  3. A Transgenic Alzheimer Rat with Plaques, Tau Pathology, Behavioral Impairment, Oligomeric Aβ, and Frank Neuronal Loss

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Neuroscience 2013 cited by 546

  4. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Brody, Richard G. Brown, James R. Burke, Joseph Butchart, Theresa A Campbell, Sandra Carusa, Roger Clarnette, Robert M. Cohen, Peter Connelly, Jacquelynn Copeland, Elizabeth Coulthard, Jill Crusey, Craig Curtis, Virginia De Sanctis, George J. Demakis, Natalie L. Denburg, Mardik Donikyan, Rachelle S. Doody, Aaron Ellenbogen, Debra Fleischman, Agnes Flöel, Concetta Forchetti, Néstor Gálvez-Jiménez, Jerome Goldstein, Felicia C. Goldstein, Kathryn Goozee, Daniel Gruener, Jerry Halsten, Howard Hassman, Elliot Henderson, Heinz-Peter Herbst, Steve Higham, Ronald Hofner, DeRen Huang, Fraser Inglis, Clark W. Johnson, Joseph S. Kass, Gregory D. Kirk, Arne Klostermann, Alex A. Knopman, Anne Koplin, David G. Krefetz, Reto W. Kressig, Rosalyn Lai, Gigi Lefebvre, Gabriel C. Léger, Mark Leibowitz, Allan I. Levey, Thomas Leyhe, Scott Losk, Kara Lyons, J F Martin, Paul J. Massman, C. McWilliam, Silvana Micallef, Lefkos Middleton, Hugh Miller, Jacobo Mintzer, Robert J. Mitchell, Ricky Mofsen, Andreas U. Monsch, Philip Moore, Donna Munic-Miller, Marshall Nash, Judith Neugroschl, Margaret Newson, Rupert Noad, Esteban Olivera, Amanda Olley, Omid Omidvar and 37 more - The Lancet Neurology 2021 cited by 117

  5. A Technique for Damping Exponential Behavior in Reactive Object Algorithms with Invalidation

    Authors: , , , , , , - Brain 1992 cited by 251

  6. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c

    Authors: , , , , , , , - Blood 2008 cited by 470

  7. The Hygiene Hypothesis – Learning From but Not Living in the Past

    Authors: , , , - Frontiers in Immunology 2021 cited by 100

  8. Low-level laser therapy for beta amyloid toxicity in rat hippocampus

    Authors: , , , , , , , , , - Neurobiology of Aging 2016 cited by 159

  9. Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man

    Authors: , , , , , , , , - New England Journal of Medicine 1994 cited by 2,492

  10. Decreased β-Amyloid1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease

    Authors: , , , , , , , , , , , - JAMA 2003 cited by 657

  11. Racial and Ethnic Differences in the Relationship between HbA1c and Blood Glucose: Implications for the Diagnosis of Diabetes

    Authors: , - The Journal of Clinical Endocrinology & Metabolism 2012 cited by 281

  12. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes

    Authors: , , , , , , , , , - Kidney International 2014 cited by 209

  13. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease

    Authors: , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 387

  14. Behavioral Phenotype in the TgF344-AD Rat Model of Alzheimer’s Disease

    Authors: , , , , , - Frontiers in Neuroscience 2020 cited by 63

  15. Ocular Changes in TgF344-AD Rat Model of Alzheimer's Disease

    Authors: , , , , , , , , - Investigative Ophthalmology & Visual Science 2014 cited by 156

  16. Discordance Between HbA1c and Fructosamine

    Authors: , , , - Diabetes Care 2003 cited by 225

  17. Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study

    Authors: , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2015 cited by 88

  18. Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review

    Authors: , , , , , , , , , , , , - Journal of Alzheimer s Disease 2013 cited by 83

  19. Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the individual burden of illness index for depression (IBI-D)

    Authors: , , - Journal of Affective Disorders 2013 cited by 78

  20. Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5‐Year Experience

    Authors: , , , , , , , , , , , - Liver Transplantation 2019 cited by 43

  21. Cerebral Glucose Metabolism in Adults with Hyperactivity of Childhood Onset

    Authors: , , , , , , , - New England Journal of Medicine 1990 cited by 981

  22. DOPA Decarboxylase Activity in Attention Deficit Hyperactivity Disorder Adults. A [Fluorine-18]Fluorodopa Positron Emission Tomographic Study

    Authors: , , , , - Journal of Neuroscience 1998 cited by 325

  23. Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial

    Authors: , , , , , , , , , , , , , , - Diabetes Care 2014 cited by 259

  24. Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele

    Authors: , , , , , , , , , , , , , - Biological Psychiatry 2004 cited by 180